SEDOL (Etoposide Injection USP) is contraindicated in patients who have demonstrated a previous hypersensitivity to Etoposide or any component of the formulation.
Sign up for Free to continue reading
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
